Rheumnow Podcast

Listen as rheumatologist Dr. Kathryn Dao and gastroenterologist Dr. Amar Naik share similarities and differences in their clinical perspectives, including a conversation on some of the benefits and risks of a JAKi in each patient population.

Dr. Jack Cush reviews this past weeks news and journal reports from RheumNow.com.  Good news is that nearly 99% of adult rheumatology positions matched! But the challenge is that 45% of pediatric fellowship programs and 39% of pediatric rheum slots were unfilled in the 2024 NRMP match

In this weeks podcast, Dr. Jack Cush reviews the ACR Convergence 2023 meeting and proposes how to best learn at large medical meetings:

An Interview with Kevin Winthrop_ Three Questions About COVID 19 Assessment and Treatment of Cardiovascular Risks in Rheumatoid Arthritis Biologics in RA_ Mechanisms of Delivery Over Mechanisms of Action_ (1) Cannabinoid Receptor in RA Patients Impact of Tofacitinib on Skeletal Muscle in RA No Increased Mortality in Patients with RA Receiving Checkpoint Inhibitors Non-TNFi b_tsDMARDs vs. TNFi in RA-ILD Older RA Patients Just Aren't Getting Treated People with RA and Long COVID Had Worse Pre-COVID RA Symptoms Reproductive History, HPV Vaccination Among Women with SLE and  RA Teledidactic vs On Campus Training in Musculoskeletal Ultrasound The SMART Study_ Split Dose Oral Methotrexate Unravelling the Mechanism of Clots with JAK Inhibitors Upadacitinib for Pain_ Is That Real_ Will CAR T Cells also treat RA_

Another TYK2 Ticks the Boxes Head to Head Comparison of Tofacitinib and TLL-018 in RA Impact of Tofacitinib on Skeletal Muscle in RA Is Point of Care Ultrasound Hocus Pocus_ JAK1 TYK2 in RA Monitoring the Effect of Therapy with a...Smart Watch_ Non-TNFi b_tsDMARDs vs. TNFi in RA-ILD Simulated JAK Trials to Counter ORAL Survelliance Treatments in SpA Unravelling the Mechanism of Clots with JAK Inhibitors Upadacitinib for Pain_ Is That Real_

An Interview with Kevin Winthrop_ Three Questions About COVID 19 Does GnRHa Reduce Premature Ovarian Insufficiency in SLE Patients on Cyclophosphamide_ Identifying New Biomarkers in the Pathogenesis of SLE-PAH Less (Glucocorticoids) is More in Lupus Nephritis Lupus and the Patient Perspective Lupus Nephritis Therapy Paradigm Shift PR3+ in Lupus Nephritis Racial and Ethnic Differences in Efficacy of Beliumumab in SLE Reproductive History, HPV Vaccination Among Women with SLE and  RA The Lupus APOL1 Story

Bimekizumab in Active AS_ 5 Year Study Deep Neural Networks and Radiographic Progression in AxSpA Difficult to Treat axSpA From AS Patient to Rheumatologist Imaging Updates in SpA INVIGORATE-1 Study_ IV Secukinumab for Treatment of Active axSpA Monitoring the Effect of Therapy with a...Smart Watch_ Overlap of Inflammatory and Degenerative Features in Radiographic axSpA People with AxSpa Need More Sleep Secukinumab vs. Adalimumab Biosimilar on Radiographic Progression in AxSpA SpA Insights_ New Therapies Teledidactic vs On Campus Training in Musculoskeletal Ultrasound Treatments in SpA Undiagnosed IBD in AxSpA Using Telemedicine to Improve Diagnosis of AxSpA

Another TYK2 Ticks the Boxes Correlation Between Patient and Physicians Assessments in PsA Difficult to Treat axSpA Effects of Apremilast on Cardiometabolic Effects in PsA EHR Algorithms Identify PsA Patients Is MSOT the New Ultrasound_ Is Point of Care Ultrasound Hocus Pocus_ SpA Insights_ New Therapies Teledidactic vs On Campus Training in Musculoskeletal Ultrasound The FOREMOST Study_ Apremilast in PsA Ultrasound for PsA Stratification_ Are We There Yet_ Window of Opportunity in PsA

Join Drs. Jack Cush and Arthur Kavanaugh as they discuss highlights and key takeaways from ACR 23.

Join our live topic panel discussion!